Rachel Esler

Improved specificity with 68Ga PSMA PET/CT to detect clinically significant lesions “invisible” on multiparametric MRI of the prostate: a single institution comparative analysis with radical prostatectomy histology

Peter Donato, Matthew J. Roberts, Andrew Morton et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2018 · 110 citations · Full text

Medicine, Nuclear Medicine, Radiology +14

68Ga-PSMA PET/CT tumour intensity pre-operatively predicts adverse pathological outcomes and progression-free survival in localised prostate cancer

Matthew J. Roberts, Andrew Morton, Peter Donato et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2020 · 107 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

68Ga-PSMA PET/CT better characterises localised prostate cancer after MRI and transperineal prostate biopsy: Is 68Ga-PSMA PET/CT guided biopsy the future?

Peter Donato, Andrew Morton, John Yaxley et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2020 · 97 citations · Full text

Medicine, Oncology, Urology +14

The use of 68Ga-PET/CT PSMA in the staging of primary and suspected recurrent renal cell carcinoma

Sheliyan Raveenthiran, Rachel Esler, John Yaxley et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2019 · 70 citations

Medicine, Nuclear Medicine, Oncology +14

Transrectal versus transperineal prostate biopsy under intravenous anaesthesia: a clinical, microbiological and cost analysis of 2048 cases over 11 years at a tertiary institution

Matthew J. Roberts, Alastair Macdonald, Sachinka Ranasinghe et al. · Prostate Cancer and Prostatic Diseases · 2020 · 34 citations · Full text

Medicine, Surgery, Urology +17